What is the market price of sunitinib in China? Price per box and medical insurance coverage

Sunitinib as a multi-target tyrosine kinase inhibitor (TKI), has been approved in China for the treatment of advanced renal cell carcinoma (RCC), gastrointestinal stromal tumors (GIST) and pancreatic neuroendocrine tumors (pNET). Due to its important role in anti-tumor treatment, there is a large market demand for this drug.

Currently, the original drug of sunitinib is produced by Pfizer (Pfizer) and is marketed in China as "Sunitinib Malate Capsules". Its common specifications include 12.5mg, 25mg and 50mg, with 28 capsules per box, and each box may be sold for about 2,000 yuan. Since medical insurance policies vary in different regions, patients need to consult the local medical insurance department or hospital for specific reimbursement information.

It is worth noting that sunitinib has been included in the National Medical Insurance Catalog as a Class B drug, and eligible patients can enjoy a certain proportion of medical insurance reimbursement, thus reducing their out-of-pocket burden. In addition, some hospitals and pharmacies may offer charitable assistance or patient assistance programs (PAP) to help financially disadvantaged patients obtain medication.

For patients who want to reduce the cost of purchasing drugs, overseas generic drugs may be an option, such as the Indian and Bangladeshi versions of sunitinib. The price of these versions is usually much lower than the original drug, and the price of each box may be around 800 yuan. However, there are certain risks in purchasing drugs overseas. It is recommended that patients carefully choose legal and safe drug purchasing channels under the guidance of doctors.

To sum up, the price of sunitinib in the Chinese market is relatively high, but the coverage of the medical insurance policy provides patients with certain economic relief. Patients should obtain drugs through formal channels based on their own conditions and follow up regularly to ensure the effectiveness and safety of treatment.

Reference materials:https://www.sutent.com/